Covance Background Image

TOGETHER, WE'VE GOT THIS.

患者不能等待
NEITHER CAN WE.™

学到更多

Tempus logo and photo of a beach

一种新的和创新招募肿瘤患者的方法

Covance and Tempus Have Joined Forces to Accelerate Patient Recruitment in Biomarker-Driven Studies

We are expanding our patient-centric approach to recruitment by incorporating the Tempus Integrated Molecular Evaluation (TIME) Trial™ Program. Learn more about how our combined recruitment capabilities can screen and match patients to biomarker trials to open a site in as few as 10 days.

阅读更多
Covance announces acquisition of snapIoT

新闻

Covance announces acquisition of snapIoT

LabCorp has announced that Covance has completed the transaction to acquire snapIoT, the fastest growing platform as a service provider of mobile-connected self-service platform solutions. This acquisition enables Covance to offer highly configurable and inter-operable patient centric solutions that enable remote participation in clinical trials, reduce patient burden while speeding implementation and improving data quality.

阅读更多
Covance Covid-19服务

我们在一起

COVID-19

Whether you are developing a COVID-19 assay, a vaccine to prevent patients from getting COVID-19, an antiviral or a treatment to mitigate the severe immunological response (cytokine storm) associated with COVID-19, we can partner with you to provide critical drug development and diagnostic services to address the global pandemic.

阅读更多
Image of a globe

新闻

Covance Announces Acquisition of GlobalCare Clinical Trials, LLC

Labcorp宣布,Covance已完成交易,以获得全球公认的分散临床试验(DCT)的全球公认的行业领导者。收购GlobalCare将扩大董事会DCTS提供进入全球市场的COT,并帮助我们满足您对患者为中心的试验设计的不断增长的需求。

阅读更多
Covance SparC创新

Covance Innovation

Patients can’t wait. And neither can we™

The healthcare industry is always looking to the future... to discover a better treatment... to deliver a cure... to prevent disease…to improve quality of life. And it’s our mission to help speed that process. What matters is not “how it’s always been done,” but how it can be done now. Better. And Faster. Through new approaches explored, ideas perfected, and transformational thinking.

阅读更多

Covance Careers

#covance potential.

这不仅仅是一份工作。对我们来说,它是个性化的。

Covance, the drug development business of LabCorp, is recognized as a leader in drug development because of our exceptional people. We embrace and celebrate the different strengths, experiences and perspectives of our 65,000+ enterprise team members across the globe. Our team is driven by an energizing purpose to improve health and improve lives. Here, you can play a role in bringing new scientific discoveries to life and make a difference in the lives of millions. Join us and discover your extraordinary potential.

探索职业生涯

Stats Image

Covance by the Numbers

年度遭遇 160M Patients
Supports Clinical Trials in 100+ 国家
合作 100% 新型肿瘤药物
帮助发展 86% 罕见的孤儿药

Contributed in the development of all the current top 50 drugs on the market

Covance Insights

Visit the Knowledge Libraryto learn more about our industry.

Subscribe Now

及时了解Covance的最新消息

学到更多